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요 약
Objective: 인체내 LDL의 증가는 동맥경화 발병과 비례한다고 알려져 있으며, 최근, LDL의 변형된 형태인 산
화 LDL(oxidized LDL) 및 여러 변형된 LDL(modifided-LDL)은 혈관내에서 macrophage와 작용하여 동맥경화의 초기단
계를 형성한다고 알려 있다. 이러한 LDL은 지질과 단백질(apo B-100)로 구성되어 있다. 동맥경화 발병과 직결된
modified-LDL의 지질 및 단백질이, 어떠한 구조적인 형태로 변화되는지 확실히 알려져 있지 않으므로, 우선
native-LDL의 형태적 특성을 조사하기 위하여, 인체 LDL에서 분리한 Apo B-100의 표면 및 중심부위에서 지질과
결합하는 peptide를 알아보고자 하였다.
Methods: 본 연구에서는 apo B-100의 표면 및 중심부위의 peptide가 지질과 결합하는 부위를 알기 위해, LDL의
단백질 성분인 apo B-100의, 지질에 둘러싸인 중심(core) 부위와 표면(surface)을 각각 분리하여, 지질을 제거한 중
심(core) 부위와, 표면(surface)부위를 trypsin과 pronase의 두가지 효소를 사용하여 peptide로 만든후, DMPC(dimyristoyl
phophatidylcholine) vesicle에 결합시켜 지질과 결합하는 부위를 연구하였다.
Results: 본 연구의 결과, LDL의 지방산 조성은 불포화 지방산으로는 linoleic acid와 oleic acid가 주요 성분이었으
며, 포화지방산은 palmitic acid와 stearic acid가 주요 성분이었다. Apo B-100의 중심(core)과 표면(surface)을 trypsin과
pronase의 두가지의 효소를 사용하여 peptide를 만든후 DMPC와 재결합 시킨후, 지질과 결합하는 peptide를 HPLC의
peptide mapping 방법으로 조사하였다. 실험의 결과, LDL의 주요 단백질인 apo B-100에서 지질과 결합이 가능한
8개의 peptide부위 (lipid-associating peptide)를 알수 있었다.
Conclusion: 이러한 결과로서, 지질과 결합되어 있는 LDL의 주요 단백질인 apo B-100는, 중심(core) 및 표면
(surface)의 여러 부위에서 광범위하게 지질과 결합되어 형성되어 있음을 알수 있었으며, 동맥경화와 관련된 변형된
LDL(modified-LDL)에서는 이와는 다른 형태의 지질 및 단백질의 결합형태를 조성되어 있을것으로 예측된다.
중심단어: LDL(Low Density Lipoprotein), apo B-100
중심 및 표면 부위의 부분(Core and surface fraction), 지질결합부위(lipid-associating peptide)
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Introduction
Apo B-100 is an important component in the
system of plasma low density lipoproteins (LDL). It
has functions as the ligand for the LDL receptor in
peripheral cells. In humans, much of the apo B-100
of VLDL is transferred to IDL and subsequently to
LDL. Apo B-100 is synthesized by liver and is an
obligatory constituent of VLDL, IDL, and LDL1,2,3.
The LDLs are removed from the circulation by
both high-affinity receptor-mediated and receptor-
independant pathways, the liver being the major
organ responsible for LDL clearance. LDLs are
removed less efficiently by the hepatic receptors
through binding to apo B-100, gradually gain access
to extravascular compartments of various organs
and tissues which contain LDL receptors, so that an
appreciable fraction is taken up in extrahepatic
tissues as well2,3. The distribution of LDL to
various tissues depends on mainly the rate of
transcapillary transport and the activity of LDL
receptors on cell surfaces.
These negatively charged regions presumably
constitute the ligand-binding sites of the receptor
which interact electrostatically with the positively
charged region of the apolipoprotein ligands.
LDL are heterogeous in their lipid contents, size
and density and small LDL subspecies may increase
risk of atherosclerosis possibly due to differences in
the conformation of apo B in the particle1,2,3.
Elavated LDL cholesterol and Apo B-100 concen-
trations are associated with an incresed risk of
atherosclerosis.
Small, dense LDL particles are more atherogenic
than larger, buoyant LDL particles. Small, dense
LDL particles contain less phospholipids and
unesterified cholesterol in their surface monolayer
than large, buoyant LDL particles. This difference
in lipid content appears to induce changes in the
conformation of apo B-100, leading to more exposure
of proteoglycan-binding regions4. Although the
primary structure of apo B-100 has been determined,
its changes in structure and conformation on LDL
are still poorly understood.
In the present study, a number of apo B-100 core
and surface peptides by enzyme digestion have
been characterized. A comparison of the behavior
of the core and surface should provide information
about the regions of apo B-100 involved in LDL
metabolism and also about the structural features
concerning on the formation of atherosclerosis. We
have studied the characterization of surface and
core fraction in order to search for physical features
of inside and outside of apo B-100. The distribution
of lipid-associating regions of the surface and core
peptide fraction of apo B-100 by recombinding
proteolytic peptides with DMPC vesicle was also
charaterized.
Materials and Methods
1. Materials
Trypsin and pronase were purchased from Sigma
chemical Co. (St. Louis.USA). Acetonitrile, methanol,
HPLC grade water, and other solvents for HPLC
were obtained from E. Merck (Darmstadt, Germany)
and J.T.Baker (Phillipsburg, USA). DMPC (dimyr-
istoyl phosphatidylcholine) was obtained from
Sigma chemical Co. (St. Louis, USA).
2. Isolation of Low Density Lipoproteins
The blood from healthy donors was used, and
aprotinin (0.055 Units/ml), 0.05% EDTA and 0.05%
NaN3 were added to the plasma. The LDL, 1.025 <
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d < 1.055 g/mL, were isolated by sequential ultracen-
trifugation using a KBr gradient at 40,000 rpm for
15 hrs at 4℃, followed by one more runs for 24
hrs under the same conditions5,6. The protein
concentration of the LDL was determined by the
method of modified Lowry et al7. Purified LDL
was dialyzed against 0.1 M ammonium bicarbonate
(NH4HCO3), pH 8.0 buffer with a No.2 dialysis bag
(Spectra/por). The purification of LDL was identified
by 5∼14% SDS-PAGE and the result was identified
if there was only one protein band at the position
of apo B-100.
3. Enzyme Digestion
Enzymatic digestion of LDL was performed with
trypsin or pronase (Fig. 1). The enzyme/substrate
ratio was 1:150 (w/w). The mixture was stirred at
room temperature for 8 hrs. The enzyme hydrolysate
was applied to a Sephadex G-50 (2.6×40 cm) column
at a flow rate of 4 ml/10 min. Each 4 mL fraction
was monitored by ultraviolet absorbance at 220
nm8,9 Surface fractions of apo B-100 generated by
digestion of LDL with trypsin or pronase and the
remaining core fragments were pooled and
lyophilyzed. The lyophilyzed core fragments were
delipidated by extracting three times with 50 ml of
ether/ethanol (3:1, v/v). Each extraction was carried
out by adding the solvent to the samples by vortex-
ing and placing the sample in a freezer (-20℃) for
1 hr, and then centrifuged at 2,000 rpm and
Fig. 1. Separation of surface and core peptide fraction from apo B-100 of human LDL.
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removed the solvent by aspiration. The core
fragments were redigested with the trypsin or
pronase (enzyme/substrate ratio was also 1:150). 50
L of surface and core fractions were used for the
idendification with 5∼14% gradient SDS-PAGE.
4. Gas Chromatography
Gas chromatography analysis was performed with
a Hitachi model 163 equipped with F.I.detector
10,11,12,13. A 2 m×3 mm (ID) glass column containing
GP 3% SP-2310/2% SP-2300 on 100/120 chrom-
osorb was used for the GLC analysis. The
temperature was as follows; injector, 220℃: column,
130℃ for 1 min, and detector, 220℃. The flow rates
were : nitrogen, 39 ml/min : hydrogen, 36 ml/min :
and air, 500 ml/min. The sensitivity and sample
size were 8×102 afs and 1 L, respectively. Chart
speed was 10 mm/min.15,17
5. Isolation of Lipid Associated Pep-
tides from Apo B-100
DMPC (dimyristoyl phosphatidylcholine) vesicles
were prepared by sonication. 300 mg of DMPC in
chloroform were placed in pyrex tube and the
organic solvent was removed with a stream of
nitrogen. The tube was placed in a lyophilizing
flask and place under a vacumn for 10 min to
remove the last traces of solvent. 15 mL of Tris
buffered saline (10 mM Tris, 1 mM EDTA, 1 mM
NaN3, 100 mM NaCl) solution was put into the
tube and placed on ice and sonicated until clarified.
The sample was centrifuged for 20 min at 10,000
rpm in a J-20 rotor to sediment the titanium
particles. The supernatant is now more than 95%
single bilayer vesicles. The digested apo B-100 (100
mg in 5 mL) was mixed with sonicated single
bilayer vesicles of DMPC (300 mg in 15 mL) at 2
4℃, the transition temperature of the lipid.
Lipid-protein complex was monitored using
UV-spectrophotometer at 220 nm. The density of
the sample was adjusted to 1.15 mg/mL by the
addition of solid KBr and subjected to
ultracentrifugation at 4℃ 30,000 rpm in a Beckman
70 Ti rotor for 18 hrs to separate the peptides that
bind to DMPC from the remainder of the peptides.
The floated lipid-protein complexes were removed
with a pasteur pipette and dissolved in 10%
sodium cholate in standard buffer before applying
the sample to a 2.8×40 cm column of Sephadex
G-50 in 0.1 M ammonium bicarbonate for desalting.
The fractions that eluted in the void volume were
lyophilized and subjected to additonal purification
by HPLC.
6. Peptide mapping of lipid binding
peptides from Apo B-100
Core and surface fragments of apo B-100 were
fractionated on a Waters HPLC system equipped
with a variable wavelength detector. The column
temperature was set at 50℃. For fractionation, a
Vydac C18 reverse phase column (1.0×25 cm) was
used with a trifluoroacetic acid (TFA) buffer system
at a flow rate 1.5 ml/min, buffer A: 0.1% TFA in
water (v/v), buffer B: 0.08% TFA on 95% acetonitrile
and 5% water (v/v/v). A linear gradient of buffer B
at 1% B per minute was applied. The eluted
fractions were monitored at 220 nm.
Results and Discussion
1. Enzyme digestion of LDL
To remove surface fraction from lipid-containing
core fraction, LDL was digested with trypsin or
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pronase (Fig. 1). A unspecific cleavage enzymes,
pronase was chosen to compare the effect of
trypsin, a specific-cleavage enzyme. Trypsin is a
pancreatic serine protease with substrate specificity
based upon positively charged lysine and arginine
side chains. But, pronase acts a unspecific endog-
enous and exogenous cleavage of apo B-100
polypeptide. Proteolytic hydrolysis of apo B-100 by
either trypsin or pronase generated peptides with
mass from approximately 20∼70 kDa14,15,17. There-
fore, pronase-digested peptides showed much smaller
size than trypsin-digested peptides. The first group
surface of apo B-100 of peptides was labelled as
trypsin-surface (TS) or pronase-surface (PS), and the
second group core of apo B-100 as trypsin-core
(TC) or pronase-core (PC). From the previous
results7, pronase digestion was more extensive to
remove exposed surface protein fraction from LDL
compared to trypsin digestion. However, elastase
digested peptide did not show any significant peaks
on HPLC peptide mapping7.
2. Fatty acid composition of LDL
Fig. 2 shows a fatty acid composition of LDL.
The major fatty acids were palmitic (16:0), oleic
(18:1) and linoleic (18:2) acid, approximately 60%
of the total fatty acid content. Palmitoleic (16:1)
and stearic (18:0) were constituted of the remaining
10%. From the above result, the major fatty acids
of LDL were palmitic and linoleic acid.
3. Lipid-binding of core and surface
peptides of apo B-100
Core and surface peptides of apo B-100 by
Fig. 2. Fatty acid pattern of LDL.
LDL was extracted with ether and ethanol (3:1,v/v). For the characterization of fatty acid
composition, the extracted lipid-moiety was separated into two subclasses, first extraction and
second extraction.
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Fig. 3. Lipid binding of core and surface peptides to DMPC single bilayer vesicles.
● : Pronase-surface, : Trypsine-surface
○ : Pronase-core, □ : Trypsine-core
Fig. 4. Gel Permeation chromatography of core and surface peptides by enzyme
digestion with Sephadex G-50
A: Trypsin-core, B: Trypsin-surface,
C: Pronase-Core, D: Pronase-surface
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enzymatic digestion were associated with DMPC
single bilayer vesicle at the transition temperature
(24℃) and then, the lipid-bound peptides from apo
B-100 were stabilized by using the cholate removal
technique. The formation of small discoidal particles
between DMPC vesicles and the apo B-100
fragments (TC, TS, PC and PS) was monitored by
measuring the absorbance at 220 nm as a function
of time (Fig. 3). DMPC binding rate of all groups
showed a progressive increase up to 10 min. And,
lipid-binding reached a maximum plateau between
10 and 16 min and decreased slowly whereas PC
showed a decrease in binding rate after 10 min.
The spontaneous association of apo B-100 peptides
with DMPC, a saturated phospholipid, was considered
by the insertion of the apo B-100 into pre-existing
lattice vacancies in the bilayer2.
4. Separation of lipid-associated
peptides by HPLC
Lipid-associated core and surface peptides were
isolated by gel permeation chromatography on a
sephadex G-50 (2.8×40 cm column) for chracter-
ization of lipid-binding peptides as illustrated in
Fig. 4. Lipid-bound peptide mixtures were collected
in void volumes (first peak) and lipid-unbound free
Fig. 5. HPLC chromatogram of the lipid-associating core and surface peptide by pronase.
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peptides (later peak) was discarded. Lipid-peptide
mixture (void volume) showed much smaller amount
than lipid-inaccessible peptides. The lipid-associated
surface and core peptides of apo B-100 were
separated and identified by HPLC. To compare the
lipid-associating regions of surface and core reptides
of apo B-100 with those of other peptides that are
known to associate with lipids spontaneously, we
have performed HPLC mapping using Vydac C18
column and TFA buffer system. The chromatograms
obtained by HPLC were shown in Fig. 5 and Fig. 6.
Lipid-associated surface and core peptide (either
pronase or trypsin digestion) showed different
HPLC chromatogram. It indicated that surface and
core peptides have different lipid-binding sites.
Lipid-bound peptides were appeared between 50
and 90 min from HPLC chromatogram, and
phospholipid peaks were shown from 10 to 50 min.
Phospholipids are much polar than lipid-associated
peptides, therefore lipid-associated peptide sample
elute later than phospholipid components.
Table 1 summarizes the retention times of lipid-
associated peptides by trypsin or pronase digestion
from HPLC chromatogram. Four major peaks for
Fig. 6. HPLC chromatogram of the lipid-associating core and surface peptide by trypsin.
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all groups (TC, TS, PC and PS) showed the
identical retention times 51, 55, 64, 69, and 83
minutes. And, other possible lipid-associating peptides
are 52 min (TS, PC, PC), 56 min (TC, TS. PS) and
75min (TC, TS, PS). Therefore, eight possible
lipid-associating peptides were found from the
HPLC chromatogram. Most of possible lipid-
associating peptide peaks were collected manually
for the identification.
The lipid-binding peptides were derived from a
mixture of small peptides from apo B-100, and
were not representative of the full apo B-100
polypeptide. Human LDL contains 80% lipid and
20% protein by weight and possess a very high
affinity for lipids8. This high affinity for lipids
suggests a structural role for apo B-100 in the
formation and maintenance of lipoprotein particles.
And Yang1 reported that lipid-binding regions of
apo B-100 are widely distributed from apo B-100
can associate in vitro with lipids to from LDL-like
particles. These results are well accord with our
findings. Reduction of the phospholipid content in
the surface monolayer LDL by treatment with
secretory phospholipase A2 (sPLA2) forms small,
Table 1. Retention times of Lipid Binding Peptides Cleavaged by
Pronase or Trypsin from HPLC Chromatogram
unit; minutes
Peak No.
Trypsin Cleavaged Peptides Pronase Cleavaged Peptides
Core Surface Core Surface
1 98.15 96.89 - -
2 - 91.91 - -
3 - 90.47 - -
4 82.70 82.57 82.13 81.58
5 75.39 75.24 72.83 74.22
6 - - - 72.26
7 39.00 69.21 68.96 68.15
8 - - - 66.36
9 63.83 63.99 63.66 63.13
10 60.59 - - 60.50
11 - 58.01 - -
12 56.62 56.89 - 55.83
13 54.88 54.97 54.61 53.85
14 - 52.04 51.13 50.60
15 51.18 51.48 51.13 50.60
16 48.95 - - -
17 - 41.08 40.93 -
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dense LDL with an enhanced tendency to interact
with ptoteoglycans19. For the characterization of the
surface and core peptides of apo B-100 from
human low density lipoprotein, LDL was digested
with either trypsin or pronase.
In conclusion, apo B-100 is an important protein
component in the system of plasma lipoprotein. It
has functions as the ligand for the LDL-receptor in
peripheral cells. And LDL is the major carrier of
cholesterol in plasma, and increased concentration is
correlated with the development of atherosclerosis23.
Changes of physical and structural properties of apo
B-100 has been known to be related to the
development of atherosclesosis, and further studies
should be continued.
Abstract
Apo B-100 is a major physical ligand for the
LDL receptor. LDLs are the major cholesterol
carrier in circulation. LDL subspecies increase risk
of atherosclerosis due to differences in the confor-
mation of apo B in the particle. The difference in
lipid content appears to induce changes in the
conformation of apo B-100, leading to more
athrogenic. In the present study, the distribution of
lipid-associating region of surface and core peptides
of apo B-100 has been investigated by recombining
peptides with DMPC vesicles. Fragments of apo
B-100 were generated by digestion of LDL with
trypsine or pronase. Proteolytic fragments and DMPC
(dimyristoyl phosphatidylcholine) were reassembled
at the transition temperature of the lipid and
stabilized by cholate. Eight lipid-associating regions
of apo B-100 were investigated by peptide mapping,
and peptides were collected as possible lipid-binding
peptides from HPLC seperation. Our results indicate
that lipid-associating regions of apo B-100 are
widely distributed within apo B-100 polypeptide.
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